Prosthetic Joint Infection (PJI) Market to Register Exponential Growth owing to the Therapeutics Advancement by Key Companies Such as Arrevus, TenNor, Peptilogics, and ContraFect

DelveInsight’s Prosthetic Joint Infection Market (PJI) Insights Report offers a detailed analysis of disease, its causes, symptoms, diagnostics modalities, and treatment options. The report also offers comprehensive insights into the Prosthetic Joint Infection therapeutics market, recent developments, epidemiology analysis, emerging therapies, market drivers, market barriers, ongoing clinical trials, and key collaboration in the space that will stimulate the market growth in the coming years. 

Some of the key highlights from the Prosthetic Joint Infection Market Insights: 

• As per DelveInsight, the total incident cases of Prosthetic Joint Infection in 7MM countries was estimated to be 72,131 in 2020. 
• The United States had the highest incident population of Prosthetic Joint Infection with 44,659 cases in 2020.
• Among the European countries, Germany had the highest population of Prosthetic Joint infections with 11,974 cases, followed by the UK in 2020.
• Japan had 1,703 cases of Prosthetic Joint Infection in 2020.
• As per DelveInsight’s assessment, the overall Prosthetic Joint Infection Incidence is expected to increase owing to the increased microorganism resistance. Further, it is subjected to increase rapidly in the coming years with the increase of Arthroplasty with supported development of robotic-assisted surgeries for Hip and knee arthroplasty.
• The prominent companies driving the Prosthetic Joint Infection Market growth include Arrevus, TenNor therapeutics, Peptilogics, ContraFect, Joint Purification Systems, and many others.
• The key therapies that are under clinical development for the treatment of PJI include Sodium Fusidate, PLG0206, TNP-2092, and others. The launch of the emerging therapies is expected to provide a new dimension to the Prosthetic Joint Infection treatment market. 

Request Sample Pages to Get More Detailed Insights @ Prosthetic Joint Infection Market Landscape 

Prosthetic Joint Infection: Overview 

PeriProsthetic Joint Infection also known as the peri-prosthetic infection is a serious complication after arthroplasty, which is associated with pain. The diagnosis and management of PJI is a serious challenge and possesses a significant burden on individual patients as well as the healthcare system. 

The most common microorganism responsible for PJI is S. aureus bacteremia. Apart from this, coagulase-negative Staphylococci and Streptococcus species, Enterococcus species, and aerobic Gram-negative bacilli are some other microorganisms responsible for PJI. Diabetes mellitus, rheumatoid arthritis, smoking, and being male are the major risk factors for PJI. It is observed that the early diagnosis of the condition can improve the therapeutic success rates for PJI tremendously. 

For more insights into Disease, causes, and treatment, reach out @ Prosthetic Joint Infection Treatment Landscape 

Prosthetic Joint Infection Epidemiology Segmentation

The Prosthetic Joint Infection Market report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:

• Total cases of Arthroplasty
• Total incident cases of Prosthetic Joint Infection
• Gender-specific cases of Prosthetic Joint Infection
• Causative Microorganism-specific cases of Prosthetic Joint Infection

Visit for more @ Prosthetic Joint Infection Epidemiological Insights 

Prosthetic Joint Infection Market

Prosthetic Joint Infection treatment aims to eradicate the infection, restore the pain-free function of the infected joint, and to minimize PJI-related morbidity and mortality. However, not all of these goals may be possible for every patient. 

The management of PJI requires surgical intervention and prolonged courses of intravenous or oral antimicrobial therapy. At present several therapies such as Sodium Fusidate, TNP-2092, PLG0206, and others are in the development stages. The launch of the therapies in the coming years is expected to improve the quality of life for the affected person. 

Prosthetic Joint Infection Pipeline Therapies and Key Companies

• Sodium Fusidate – Arrevus
• PLG0206 – Peptilogics
• TNP-2092 – TenNor Therapeutics
• Exebacase – ContraFect
• Vancomycin hydrochloride and tobramycin sulfate – Joint Purification Systems

For more information, visit Prosthetic Joint Infection Market Analysis, Patient Pool, and Emerging Therapies 

Prosthetic Joint Infection Market Drivers

• An increase in Joint Arthroplasties
• Rapid technological development
• Advancement in Human Genomics
• Favorable Environment for New Anti-infective Modalities

 

Scope of the Report

• 11 Years Forecast
• 7MM Coverage 
• Descriptive overview of Prosthetic Joint Infection, covering causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
• Comprehensive insight into Prosthetic Joint Infection epidemiology and treatment in the 7MM
• Current and emerging therapies for Prosthetic Joint Infection 
• Prosthetic Joint Infection market drivers and barriers 

Key Questions Answered in the Report

• What would be the Prosthetic Joint Infection market share (%) distribution in 2030 across the 7MM, and what it was in 2018?
• What would be the Prosthetic Joint Infection total market size as well as market size by therapies across the 7MM during the forecast period (2018-2030)?
• What are the recent development in the Prosthetic Joint Infection market and how it will affect the 7MM in the coming years?
• Which country will have the largest Prosthetic Joint Infection market size during the forecast period (2018-2030)?
• What are the factors that will affect the Prosthetic Joint Infection market growth and at what CAGR the market will grow in the 7MM during the forecast period (2018-2030)?

Get in touch with our Business executive @ Prosthetic Joint Infection Market Landscape Analysis 

Table of Contents 

1	Key Insights
2	Report Introduction
3	Competitive Intelligence Analysis for Prosthetic Joint Infection
4	Prosthetic Joint Infection Market Overview at a Glance
5	Executive Summary of Prosthetic Joint Infection
6	Prosthetic Joint Infection Epidemiology and Market Methodology
7	Prosthetic Joint Infection Epidemiology and Patient Population
8	Prosthetic Joint Infection Patient Journey
9	Treatment Algorithm, Current Treatment, and Medical Practices
10	Key Endpoints in Prosthetic Joint Infection Clinical Trials
11	Prosthetic Joint Infection Marketed Therapies
12	Prosthetic Joint Infection Emerging Therapies
13	Prosthetic Joint Infection: 7 Major Market Analysis
14	Attribute analysis
15	Access and Reimbursement Overview of Prosthetic Joint Infection
16	KOL Reviews
17	Case Reports
18	Prosthetic Joint Infection Market Drivers
19	Prosthetic Joint Infection Market Barriers
20	SWOT Analysis
21	Disclaimer
22	DelveInsight Capabilities
23	About DelveInsight

Learn more about the report offerings @ Prosthetic Joint Infection Market Outlook

Latest Reports–

Prosthetic Joint Infection (PJI) Epidemiology Forecast
DelveInsight’s “Prosthetic Joint Infection (PJI) Epidemiology Forecast 2030” report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Prosthetic Joint Infection (PJI) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Prosthetic Joint Infections Pipeline Insights
DelveInsight’s “Prosthetic Joint Infection (PJI) Pipeline Insight, 2020” report outlines comprehensive insights of present clinical development scenario and growth prospects across the DelveInsight’s market.

Endometrial Cancer Market
DelveInsight’ s “Endometrial Cancer Market Insights, Epidemiology, and Market Forecast 2030” report provides a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology as well as the Endometrial Cancer H3N2 Infection Market Trends in the 7MM.

H3N2 Infection Market
DelveInsight’ s “H3N2 Infection Market Insights, Epidemiology, and Market Forecast 2030” report provide a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology as well as the H3N2 Infection Market Trends in the 7MM.

Axial Spondyloarthritis Market
DelveInsight’ s “Axial Spondyloarthritis Market Insights, Epidemiology, and Market Forecast 2030” report provide a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology as well as the Axial Spondyloarthritis Market Trends in the 7MM.

Sinusitis Market
DelveInsight’ s “Sinusitis Market Insights, Epidemiology, and Market Forecast 2030” report provide a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology as well as the Sinusitis Market Trends in the 7MM.

Neurovascular Thrombectomy Devices Market
DelveInsight’s ‘Neurovascular Thrombectomy Devices Market Insights, Competitive Landscape and Market Forecast–2026’ report delivers an in-depth understanding of Neurovascular Thrombectomy Devices and the historical and forecasted Neurovascular Thrombectomy Devices market Market Trends in the 7MM.

Healthcare Blogs By DelveInsight – 

• Eye Disorders Market
• Spinal Stenosis Devices Market
• Key MedTech Companies
• Key Companies in Migraines Market
• Aducanumab Approved for Treatment of Alzheimer’s
• Recent Developments in the Pacemakers Pipeline
• Endoscopy Fluid Management Systems Market
• Elastomeric Pumps market growth
• Key Companies in Bone Cancer Market 
• Adult-Onset Still’s Disease Market

 

Get in touch with our Business executive for Competitive Intelligence Services

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect With Us at LinkedIn | Facebook | Twitter

The post Prosthetic Joint Infection (PJI) Market to Register Exponential Growth owing to the Therapeutics Advancement by Key Companies Such as Arrevus, TenNor, Peptilogics, and ContraFect appeared first on Financial Market Brief.